International Catalogue 2020/2021 - Immunohistochemistry - Selected Reagents for Diagnostics and Research - Zytomed Systems
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Immunohistology
Detection Systems
Ancillary Reagents
Control Material
International Catalogue 2020/2021
Immunohistochemistry – Selected Reagents for Diagnostics and Research
Zytomed Systems GmbH
Anhaltinerstraße 16 | 14163 Berlin
Phone +49 30 80 49 84 990 | Fax +49 30 80 49 84 999
international@zytomed-systems.de | www.zytomed-systems.com
2
Content
Antibodies
Positive control list for primary antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Information about Zytomed Systems antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Selected primary antibodies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Max-Line antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Detection Systems
ZytoChem Plus Polymer detection kits and reagents .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
Double Stain Polymer detection kits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
ZytoChem Plus Streptavidin Biotin detection kits and reagents .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
Ancillary Reagents
Epitope retrieval .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
Chromogenic substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Diluents, buffers and miscellaneous .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Control Material
Cell Control Blocks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
Cell Control Slides. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Information
Master list for immunohistochemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Register . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
3
3 3
www.zytomed-systems.com
Antibodies
Antibodies
4 www.zytomed-systems.com
Compilation of positive controls for primary
antibodies used in immunohistochemistry
Antigen/Antibody Positive control Antigen/Antibody Positive control
Antibodies
14-3-3 Beta Protein Prostate carcinoma, liver tumour CA 125 Antigen Ovary carcinoma,
14-3-3 Zeta Protein Breast carcinoma colon carcinoma
ACTH Pituitary gland Cadherin (Pan) Tonsil
Actin (Muscle) Skeletal muscle Cadherin 17 Colon carcinoma
Actin (Muscle, Pan) Skeletal muscle E-Cadherin Ductal breast carcinoma
Actin alpha (Sarcomeric) Skeletal muscle Calbindin Kidney
Actin alpha (Skeletal Muscle) Skeletal muscle Calcitonin Thyroid gland
Actin alpha (Smooth Muscle) Leiomyosarcoma Caldesmon (HMW) Skeletal muscle
Actinin alpha Skeletal muscle
Calmodulin-dependend Protein Kinase IV Brain
Adenovirus Adenovirus-infected tissue
Calpain Breast carcinoma
ADH-5 (Breast Marker Double Stain Cocktail) Breast carcinoma
Calpastatin Breast carcinoma
AFP (Alpha Fetoprotein) Fetal liver
Calponin Breast carcinoma
Akt1 Breast carcinoma
Calretinin Mesothelioma
Akt1/2 Breast carcinoma
Albumin (HSA) Liver
Carbonic Anhydrase IX (CA IX) Placenta
Aldh 1a1 (Alkohol Dehydrogenase 1) Colon carcinoma, breast carcinoma Caspase 1 Clear cell RCC
ALK /p80 (Anaplastic Lymphoma Kinase) ALK-positive lymphoma Caspase 3 (CPP32) Tonsil
Alpha-1-Antichymotrypsin Tonsil Caspase 3, cleaved (CPP32) Tonsil, colon carcinoma, apoptotic cells
Alpha-1-Antitrypsin (AAT) Tonsil Caspase 6 (MCH2) Tonsil
Alpha-2-Macroglobulin Tonsil Caspase 8 (FLICE) Stomach
Amylin (Peptide) Pancreas Caspase 9 (Apaf-3) Stomach, tonsil
Amyloid A Component Kidney Caspase 10 (FLICE2) Liver carcinoma
Amyloid Beta (A4) Alzheimer brain Catenin (alpha) Breast carcinoma
Amyloid Beta-Protein Alzheimer brain Catenin (beta) Breast carcinoma
Amyloid Precursor Protein (APP) Brain Catenin (delta), p120 Breast carcinoma
Androgen Receptor Prostate carcinoma Catenin (gamma) (Plakoglobin) Breast carcinoma
Annexin A1 Hairy cell leukaemia Cathepsin D Breast carcinoma
Annexin IV Liver Cat Scratch Disease Bartonella henselae-infected tissue
APC (Adenomatous Polyposis Coli) Colon carcinoma Caveolin-1 Lung carcinoma
ATM (Ataxia Telangiectasia Mutated) Breast carcinoma CCR7 Small intestine
BAG-1/RAP46/HAP1 Breast carcinoma CD1a Histiozytosis X, tonsil
Bak Tonsil
CD2 Tonsil
Bax Hodgkin’s Lymphoma
CD3 Tonsil
BCA-225 (BRST-1) Breast carcinoma
CD3 zeta Jurkat cells, tonsil
BCL2 Tonsil
CD4 Tonsil
BCL6 Tonsil
CD5 Tonsil, mantle cell lymphoma
BCL10 Tonsil
BCL-X Hodgkin’s lymphoma
CD7 Tonsil
BCL-XL Hodgkin’s lymphoma CD8 Tonsil
BCRP Drug-sensitive cell line (MCF-7), fetal intestine CD9 Tonsil
beta-HCG Placenta CD10 (CALLA) Small intestine, tonsil
BG-1 Precursor (Blood Group Antigen) Kidney, ureter CD11c Hairy cell leukaemia
BG-2 A (Blood Group Antigen) Kidney, ureter CD14 Tonsil, diffuse large-cell
BG-3 B (Blood Group Antigen) Kidney B-cell lymphoma
BG-4 0 (Blood Group Antigen) Colon, colon carcinoma CD15 Reed-Sternberg cells, tonsil
BG-5 Lewis a (Blood Group Antigen) Colon, colon carcinoma CD19 Tonsil
BG-6 Lewis b (Blood Group Antigen) Colon carcinoma CD20 Tonsil
BG-7 Lewis x (Blood Group Antigen) Kidney CD21 Tonsil
BG-8 Lewis y (Blood Group Antigen) Colon carcinoma CD23 Tonsil
BOB.1 Tonsil, lymph node CD25 Tonsil
BRCA1 Ovary carcinoma CD29 (Integrin-beta1) Cerebellum
C3d Graft rejection after kidney transplantation CD30 (Ki-1) Small intestine, tonsil
C4d Graft rejection after kidney transplantation CD31 (PECAM-1) Placenta, tonsil
CA 19-9 (Colon) Colon carcinoma CD34 (Endothelial cells) Tonsil
CA 72.4 Antigen/TAG-72 (BRST-3) Breast carcinoma CD35 (CR1) (Dentritic Reticulum) Tonsil
5
Antigen/Antibody Positive control Antigen/Antibody Positive control
CD40 Tonsil Cyclin B1 Breast carcinoma, tonsil
CD43 (Leukosialin, Sialophorin) Lymph node, tonsil Cyclin D1 (BCL-1) Breast carcinoma, mantle
CD44 (H-CAM) Tonsil cell lymphoma, tonsil
CD45 (LCA) Tonsil Cyclin D3 Breast carcinoma, tonsil
CD45RA Tonsil Cyclin E Breast carcinoma, placenta
Antibodies
CD45RB Tonsil Cyr61 Placenta
CD45RO Lymph node, tonsil Cystatin A Brain
CD56 (N-CAM, NKH1, SCLC) Small-cell lung carcinoma, neuroblastoma Cytokeratin (Acidic) Skin
CD57 (NK cells) Lymph node, tonsil Cytokeratin (Basic) Skin
CD61 (Integrin beta 3) Tonsil Cytokeratin (HMW) Skin, prostate
CD63 (NK-I/C3) Melanoma Cytokeratin (OSCAR) Bladder, skin, liver, breast carcinoma
CD68 (Macrosialin, Tonsil Cytokeratin (Pan) Skin, tonsil
macrophage antigen) Cytokeratin Pan Plus Skin, adenocarcinoma
CD74 Tonsil Cytokeratin (Wide Spectrum) Skin
CD79a Tonsil Cytokeratin 4 Skin
CD95 (Fas, Apo-1) Small intestine Cytokeratin 5 Skin
CD95L (FAS Ligand) CD178 Prostate Cytokeratin 5 & 6 Skin, prostate
CD99/MIC2 (Ewing’s sarcoma) Ewing sarcoma, pancreas Cytokeratin 5 & 8 Skin, lung
CD105 (Endoglin, TGF beta 1/3 Receptor) Tonsil Cytokeratin 5 & 14 Skin, prostate
CD117 (c-Kit) Tonsil, stroma tumour (GIST) Cytokeratin 6 Skin
CD138 (Syndecan-1) Plasmocytoma, tonsil Cytokeratin 7 Skin, breast carcinoma
CD163 Lung Cytokeratin 8 Skin
CD274 (B7-H1) Tonsil, lung, skeletal muscle Cytokeratin 8 & 18 Skin, breast carcinoma
CDC25A Tonsil Cytokeratin 10 Skin
CDC25B Tonsil Cytokeratin 10 & 13 Skin
CDC25C Breast carcinoma Cytokeratin 13 Skin
CDC37 Thymus Cytokeratin 14 Skin, squamous cell carcinoma
CDC47 Breast carcinoma Cytokeratin 15 Skin
Cdk2 (Cyclin dependent Kinase 2) Tonsil Cytokeratin 16 Skin, squamous cell carcinoma
Cdk4 (Cyclin dependent Kinase 4) Liposarcoma Cytokeratin 17 Skin
Cdk5 (Cyclin dependent Kinase 5) Brain Cytokeratin 18 Skin, lung carcinoma, breast carcinoma
CDw75 (B-Cell) Tonsil Cytokeratin 19 Skin, colon carcinoma
CDX1 Small intestine Cytokeratin 20 Colon carcinoma
CDX2 Colon carcinoma Cytomegalovirus (CMV) CMV-infected tissue
CEA (Carcinoembryonic Antigen, CD66e) Colon carcinoma Desmin Leiomyoma
c-FOS Skin Desmoglein 3 Breast carcinoma
CFTR Pancreas DHFR (Dihydrofolate Reductase) Squamous cell carcinoma of lung
Cholecystokinin (26-33) Small intestine DNA Polymerase B Testicles
Chromogranin A Pancreas DOG1 Gastrointestinal stroma tumour
CITED-1 (CBP, CREB-binding Papillary thyroid gland carcinoma Dysferlin Skeletal muscle
protein, p300) Dystrophin Skeletal muscle
Claudin 1 Skin, breast carcinoma E2F-1 Transcription Factor Breast carcinoma, tonsil
Claudin 2 Colon carcinoma, ovary carcinoma, tonsil E2F-4 Transcription Factor Breast carcinoma, tonsil
Claudin 3 Small intestine E-Cadherin Ductal breast carcinoma
Claudin 4 Ovary carcinoma, tonsil EGFr (Epidermal Growth Factor Receptor) Placenta, squamous cell carcinoma
Claudin 5 Colon carcinoma, lung Elastin Heart
Claudin 7 Colon carcinoma EMA (Epithelial Membrane Antigen) Colon carcinoma, breast carcinoma
Claudin 10 Brain, skeletal muscle eNOS (endothelial NO-Synthase) Vascular endothelia
c- Met (Hepatocyte Growth Breast carcinoma Epithelial Specific Antigen (ESA, Ep-CAM) Breast carcinoma
Factor Receptor) Epstein Barr Virus (EBV)(Cocktail)(LMP-1) EBV-infected tissue
c-Myc Breast carcinoma ERAB Alzheimer brain
Collagen IV Skin ERCC1 Tonsil, lung carcinoma
Connexin 43 Heart ERG Prostate carcinoma
COX-1 (Cyclooxygenase 1) Skin ERK1 (Extracellular Regulated Kinase) Breast carcinoma
COX-2 (Cyclooxygenase 2) Colon carcinoma, breast carcinoma ERK2 (Extracellular Regulated Kinase) Breast carcinoma
c-TEN Liver carcinoma Estrogen Receptor Breast carcinoma
CUL-1 Tonsil Estrogen Receptor beta Breast carcinoma, ovary, endometrium
CUL-2 Tonsil Ezrin (p81, Cytovillin) Lung
CUL-3 Tonsil F4/80 Mouse lung
Cyclin A Tonsil Factor VIII Related Antigen (v. Willebrand Factor) Tonsil
6 www.zytomed-systems.com
Antigen/Antibody Positive control Antigen/Antibody Positive control
Factor XIIIa (Fibrinoligase, Placenta HSV I & II (Herpes Simplex Virus) HSV I & II-infected tissue
Plasma Transglutaminase) HSV II (Herpes Simplex Virus) HSV II-infected tissue
Fas-Associated Phosphatase (FAP-1) Placenta Huntingtin-Interacting Protein 1 (HIP-1) Colon carcinoma
FBXW7 Endometrial adenocarcinoma Lung squamous cell carcinoma IgA Tonsil
FGFr1 (Fibroplast Growth Factor Receptor) Breast carcinoma IgD Tonsil
Antibodies
FGFr2 (Fibroplast Growth Factor Receptor) Liver cell carcinoma IgE Tonsil
FGFr3 (Fibroplast Growth Factor Receptor) Breast carcinoma IgG Tonsil
Fibronectin Kidney IgG4 Tonsil
Fli-1 Angiosarcoma IgM Tonsil
FLIP (Flice Inhibitor Protein) Colon carcinoma, placenta IKAROS Tonsil
Follicular Dendritic Cells (FDC) Lymph node, thyroid gland, tonsil Inhibin, alpha Ovary, testicles
FOXA1 Breast carcinoma INI-1 Brain, astrocytome, endothelial cells
FOXP3 Tonsil iNOS (inducible NO-Synthase) Lung
FOXP4 (Forkhead BOX P4) Lung Insulin Pancreas
Fra2 (Fos Related Antigen 2) Prostate carcinoma Insulin-Like Growth Factor 1 Receptor (IGF1R) Breast carcinoma, placenta
FSH (Follicle Stimulating Hormone) Pituitary gland Insulin Receptor Substrate (IRS) Colon carcinoma
Galectin-3 Thyroid gland Integrin beta 3 (CD61) Tonsil
Gamma Glutamylcysteine Synthase (GCS) Kidney, testicles Integrin beta 5 Small intestine, bone marrow
Gastrin Stomach Involucrin Skin
GATA-3 Breast, urothelial carcinoma IPO-38 (Proliferation Marker) Spleen, tonsil
GCDFP-15 (BRST-2) Breast carcinoma, salivary gland JAK3 Colon carcinoma, tonsil
GFAP (Glial Fibrillary Acidic Protein) Astrocytome, brain J-Chain Tonsil
Glial Derived Neurotrophic Factor Brain tumour Kappa Light Chain Tonsil
Glucagon Pancreas Ki-67 Breast carcinoma, tonsil
GLUT1 (Glucose Transporter 1) Breast carcinoma KOC/L523S Prostate carcinoma, placenta
GLUT3 (Glucose Transporter 3) Placenta K-RAS Colon carcinoma
Glutamat Decarboxylase 65 Pancreas Ksp-Cadherin Kidney
Glycophorin A Erythrocytes Ku (p70) Tonsil
Glycophorin C (CD236R) Tonsil Lactogen (Placental) Placenta
Glypican-3 Liver cell carcinoma Lambda Light Chain Tonsil
GNB2 (Guanine nucleotide binding protein 2) Placenta Laminin Skin
Granulocyte (Myeloid Cell Marker) Lymph node, tonsil Langerin Langerhans cells
Granzyme B Hodgkin’s lymphoma, tonsil LK26 Ovary carcinoma
Growth Hormone, human (hGH) Pituitary gland LMO2 Tonsil
Hairy Cell Leukemia Tonsil LPAP (Lymphocyte Phosphatase-Associated Tonsil
HCG (Human Chorionic Gonadotropin) Placenta Phosphoprotein)
HDAC1 (Histone Deacetylase 1) Tonsil Lung Related Protein, MV Breast carcinoma, adrenal gland
HDAC2 (Histone Deacetylase 2) Tonsil (Major Vault Protein)
Heat Shock Protein 60 (HSP60) Breast carcinoma Luteinizing Hormone (LH) Pituitary gland
Heat Shock Protein 70 (HSP70) Breast carcinoma Lymphatic Endothelium Marker Lymphatic endothelia (tonsil
Helicobacter pylori H. pylori-infected tissue (D2-40, Podoplanin) or appendix)
Hemoglobin A Bone marrow, spleen, placenta Lysozyme (Muraminidase) Tonsil
Hepatitis B Core Antigen (HBcAg) HBV-infected liver LYVE-1 Lymphatic endothelia (tonsil
Hepatitis B Surface Antigen (HBsAg) HBV-infected liver or appendix)
Hepatitis C Virus (HCV) HCV-infected liver Macrophage Lymph node, tonsil
Hepatocyte (HepPar1) Liver MAdL Adenocarcinoma of lung
Hepatocyte Factor Homologue-4 Lung MAGE-1 Melanoma, tonsil
HER2 (c-erbB-2) Extracellulär domain Breast carcinoma Mammaglobin Breast carcinoma
HER2 (c-erbB-2) Intracellulär domain Breast carcinoma MART-1 (MelanA) Melanoma
HER3 (c-erbB-3) Breast carcinoma, skeletal muscle Mast Cell Chymase Tonsil
HER4 (c-erbB-4) Breast carcinoma Mast Cell Tryptase Tonsil
Heregulin (NDF, GGF, Neuregulin) Prostate carcinoma MCL-1 (Myeloid Cell Leukemia) Tonsil
HGAL Tonsil, lymph node MCM2 Tonsil
HHV8 (Human Herpes Virus) HHV8-infected tissue MCM5 Cervix carcinoma
HIF-1 alpha ( Hypoxia Inducible Breast carcinoma MDM2 (Murine Double Minute 2) Breast carcinoma, liposarcoma
Factor-1 alpha) MDR1 (Multi Drug Resistance Colon, liver, kidney
HLA-DR, DP, DQ, DX Lymph node, tonsil Protein, pg170J)
HMGA2 Breast carcinoma MDR1+3 (Multi Drug Resistance Protein) Adrenal cortex
HPV 16, L1 (Papilloma virus Type 16) HPV 16-infected tissue MEF-2 Brain
HSV I (Herpes Simplex Virus) HSV I-infected tissue
7Antigen/Antibody Positive control Antigen/Antibody Positive control
Melanoma Melanoma Oct-2 (Octamer Binding Tonsil
(pan, MART-1+HMB45+Tyrosinase) Transcription Factor 2)
Melanoma (HMB45) Melanoma Oct-3/Oct-4 (Octamer Binding Seminoma
Melanoma Associated Antigen Melanoma Transcription Factor 3/4)
Mesothelin Mesothelioma Oct-4 (Octamer Binding Seminoma
Antibodies
Mesothelioma Mesothelioma Transcription Factor 4)
MGMT Colon carcinoma, tonsil Osteopontin Stomach carcinoma, osteosarcoma
Microglia (Iba1) Brain Olig2 Astrocytoma
MIP-1alpha Lung carcinoma p14 (ARF) Breast carcinoma, cervix carcinoma
MiTF (Microphthalmia Melanoma p14 (ARF)/p16 beta Cervix carcinoma, fibroadenoma of breast
Transcription Factor) p15 (ink4b) Colon carcinoma
MLH1 Colon, melanoma, tonsil p16 (ink4a) Uterine cervical squamous cell carcinoma
MMP-1 (Matrix Metalloproteinase 1) Breast carcinoma, placenta p19 (ink4d) Colon carcinoma
MMP-2 (Matrix Metalloproteinase 2) Breast carcinoma, placenta p21 (ros, WAF1) Colon carcinoma, tonsil
MMP-3 (Matrix Metalloproteinase 3) Breast carcinoma, placenta p27 (KIP1) Colon carcinoma
MMP-7 (Matrix Metalloproteinase 7) Breast carcinoma, placenta p34 (CDC2) Breast carcinoma
MMP-9 (Matrix Metalloproteinase 9) Breast carcinoma, placenta p40 Squamous cell carcinoma of lung
MMP-10 (Matrix Metalloproteinase 10) Breast carcinoma, placenta p53 Colon carcinoma, breast carcinoma
MMP-11 (Matrix Metalloproteinase 11) Placenta p56 DOK2 Breast carcinoma
MMP-14/MT-MMP Breast carcinoma, placenta p57 (KIP2) Colon carcinoma, placenta
(Matrix Metalloproteinase 14) p59 (Fyn) Lymphoma
MMP-15/MT2-MMP Placenta p62 DOK1 Breast carcinoma
(Matrix Metalloproteinase 15) p63 Skin, squamous cell carcinoma, prostate
MMP-19 (Matrix Metalloproteinase 19) Placenta p120 (Catenin delta) Breast carcinoma
MMP-23 (Matrix Metalloproteinase 23) Placenta P504S (AMACR) Prostate carcinoma
MSH2 (MutS homologue 2) Colon carcinoma, tonsil P504S & p63 (PIN Cocktail) Prostate carcinoma
MSH3 (MutS homologue 3) Colon carcinoma, tonsil Pan Basal-Cell Cocktail Prostate, breast
MSH6 (MutS homologue 6) Colon carcinoma, tonsil (p63 & Cytokeratin 5/14)
mTOR Breast carcinoma Pan B Cocktail (CD20 & PAX-5) Tonsil
MUC1 (Mucin 1, CD227) Breast carcinoma Pancreatic Polypeptide Pancreas
MUC2 (Mucin 2) Small intestine Par-4 (Prostate Apoptosis Response) Alzheimer brain, myocardium
MUC 5AC (Mucin 5AC) Stomach Parathyroid Hormone (PTH) Parathyroid gland
MUC18 (CD146) Angiosarcoma Parathyroid Hormone Receptor 1 (PTHr) Breast carcinoma
MUM1 Protein Plasma cells, tonsil PAX-2 Kidney cell carcinoma
Myelin Basic Protein (MBP) Brain PAX-5 Tonsil
Myeloperoxidase (MPO) Spleen, tonsil PAX-8 Kidney cell carcinoma
Myo D1 Tonsil Paxillin Colon carcinoma
Myogenin Rhabdomyosarcoma PCNA (Proliferating Cell Nuclear Antigen) Lymph node, tonsil
Myoglobin Skeletal muscle PD-1 Tonsil, lymph node
Myosin Skeletal muscle PDGF (Platelet Derived Growth Factor) Breast carcinoma
Napsin A Adenocarcinoma of the lung PDGF (beta-chain) Angiosarcoma
NCK2 Breast carcinoma (Platelet Derived Growth Factor)
N-Cadherin (Cadherin 2) Pituitary gland PDGFr-alpha (CD140a) Ovary carcinoma
Nephrin Kidney PDGFr-beta (CD140b) Ovary carcinoma
Neurofilament H (200 kDa) Brain PD-L1 Tonsil, lung adenocarcinoma
Neurofilament l & H (70/200 kDa) Brain Perforin Spleen
NF kappa B (p50) Testicles Phosphohistone H3 (pHH3) Breast carcinoma, tonsil
NF kappa B (p65) (rel A) Placenta, prostate Phospholipase C beta 1 Brain
NGF-Receptor Neurofibroma Phospholipase C gamma 2 Hodgkin’s lymphoma
Nkx3.1 Prostate carcinoma Phosphoprotein (Pan) (PS/PT/PY) Breast carcinoma
eNOS (endothelial NO-Synthase) Vascular endothelia Phosphotyrosine Breast carcinoma
iNOS (inducible NO-Synthase) Lung PI3K/p85 Placenta, Breast carcinoma
uNOS (universal NO-Synthase) Placenta PI3K/p110 beta Placenta
Notch-1 Colon carcinoma, breast carcinoma PIN Cocktail (P504S & p63) Prostate carcinoma
Nrf2 (TCF 11) Placenta PLAP (Placental Alkaline Phosphatase) Seminoma
NSE (Neuron Specific Enolase) Pancreas PML Protein Lymphoma
Nucleophosmin (NPM, Numatrin) Tonsil PMP22 (Peripheral Myelin Protein) Nerve tissue
Occludin Lung, A431 cells PMS2 Colorectal carcinoma
Oct-1 (Octamer Binding Tonsil Pneumocystis carinii Infected lung tissue
Transcription Factor 1) Podocin Kidney
8 www.zytomed-systems.comAntigen/Antibody Positive control Antigen/Antibody Positive control
Podoplanin Lymphatic endothelia TFE3 Testis or renal cell carcinoma
Progesterone Receptor Breast carcinoma with Xp11.2 translocation
Prohibitin Heart TGF alpha (Transforming Growth Factor) Small intestine
Prolactin (LTH, Luteotropic Hormone) Pituitary gland TGF beta I (Transforming Growth Factor) Placenta
Protein Gene Product 9.5 (PGP9.5, UCH-L1) Pancreatic carcinoma, tonsil TGF beta I Receptor Placenta
Antibodies
PSA (Prostate Specific Antigen) Prostate TGF beta II (Transforming Growth Factor) Small intestine
PsAP (Prostatic Acid Phosphatase) Prostate TGF beta III (Transforming Growth Factor) Placenta
PsCA (Prostate Stem Cell Antigen) Prostate carcinoma TGF beta III Receptor Placenta
PSMA (Prostate Specific Membrane Antigen) Prostate Thioredoxin Reductase 2 (TrxR2) Colorectal carcinoma
PTEN (MMAC1,TEP1) Prostate, breast carcinoma Thrombin R Pancreas
PU.1 Lymph node, tonsil Thrombospondin (TSP) Breast carcinoma
Ran Mamma, Hela- or A431 cells Thymidine Phosphorylase Breast carcinoma
Ras Tonsil Thymidylate Synthase Colon carcinoma
RCAS (BAG9) Breast carcinoma Thyroglobulin Thyroid gland
RCC1 (Regulator of Chromosome Colon carcinoma Thyroid Hormone Receptor alpha 1/2 Colon carcinoma
Condensation1) Thyroid Hormone Receptor beta Thyroid gland
Renal Cell Carcinoma, gp200 (RCC) Kidney, kidney cell carcinoma Thyroid Peroxidase (TPO) Breast carcinoma, ovary carcinoma
Ret Oncoprotein Small intestine, Colon carcinoma, TIE-1 Tonsil
Retinoblastoma (Rb) Breast carcinoma TIMP-1 (Tissue Inhibitor Colon carcinoma, pancreas
R0C1 Tonsil of Metalloproteinase) carcinoma
RPA (p34) (Replication Protein A) Tonsil TIMP-2 (Tissue Inhibitor of Metalloproteinase) Breast carcinoma, Placenta
RRM1 (Ribonucleotide Reductase Placenta TIMP-3 (Tissue Inhibitor of Metalloproteinase) Breast carcinoma, Placenta
M1 Polypeptide) TNF (alpha) Spleen
S6 Ribosomal Breast carcinoma TNFr-2 (Tumor Necrosis Tonsil
S100 Melanoma, nerve tissue Factor Receptor 2)
S100A4 Melanoma Topoisomerase II (alpha) Tonsil, mantle cell lymphoma
S100P Ductal adenocarcinoma of pancreas Topoisomerase II (beta) Tonsil
SALL4 Seminoma Toxoplasma gondii Infected brain tissue
SATB2 Colorectal adenocarcinoma TRADD Liver carcinoma
Secretagogin Pancreas, brain Transferrin Liver
Serotonin Small intestine Transglutaminase II Breast carcinoma
Smad3 Breast carcinoma Treponema pallidum Infected tissue
SMAD4 (DCP4) Placenta Trypsin Pancreas
Somatostatin Receptor 1 (SSTR1) Prostate TSH (Thyroid Stimulating Hormone) Pituitary gland
Somatostatin Receptor 2A (SSTR2A) Pancreas including Langerhans cells TTF-1 (Thyroid Transcription Factor 1) Lung, thyroid gland
Somatostatin Receptor 5 (SSTR5) Pancreas including Langerhans cells Tubulin, alpha Skin, lung
SOX2 Newborn brain Tubulin, beta Skin, lung
SOX4 Brain Tyrosinase Melanoma
SOX9 Testicles Ubiquitin Alzheimer brain
SOX10 Malignant melanoma, melanocytes uNOS (universal NO-Synthase) Umbilical cord, placenta
SOX11 Mantle cell lymphoma Upstream Transcription Factor 2 (USF2) Breast carcinoma
SOX14 Fetal tissue Urocortin Pituitary gland
STAT3 Tonsil Uroplakin II Urothelial tissue
STAT5a Tonsil Uroplakin III Urothelial tissue
STAT6 Breast carcinoma Urothelial carcinoma
Stathmin Tonsil, breast carcinoma, Jurkat-cells VEGF-A (Vascular Astrocytome, haemangiosarcoma
Surfactant Apoprotein-A Lung carcinoma Endothelial Growth Factor)
Survivin Lymphoma VEGFr-1 (Flt-1) Angiosarcoma
Synaptophysin Pancreas VEGFr-2 (Flk-1) Angiosarcoma
Syndecan-1 (CD138) Tonsil VEGFr-3 (Flt-4) Placenta, breast carcinoma
Syntaxin 1A Brain VGSC Brain
Synuclein (alpha) Brain Villin Small intestine, kidney
Synuclein (beta) (Phosphoneuroprotein 14) Brain Vimentin Skin, melanoma, sarcoma
Synuclein (Pan) Colon carcinoma, breast carcinoma Vinculin Skin
TAG-72 (Tumor associated Glycoprotein) Alzheimer brain WNT1 Breast carcinoma
TAU Thymus WT1 (Wilm‘s Tumor Protein-1) Wilm’s tumour
T-bet Tonsil, hairy cell leukaemia XRCC1 Testicles
TdT (Terminal Deoxynucleotidyl Squamous cell XRCC2 Testicles
Transferase) carcinoma, tonsil ZAP-70 Tonsil
Tenascin C Tonsil, appendix ZO-3 Small intestine
This information is supplied without liability.
9Selected Primary Antibodies
for formalin-fixed paraffin-embedded tissue sections
Zytomed Systems offers a broad range of antibodies suitable for diagnostics. Usually, our antibodies are
Antibodies
available in concentrated and ready-to-use formats. All antibodies mentioned here are suitable for FFPE
tissue sections.
Ready-to-use antibodies: Designed for convenient handling, these antibodies require no dilution or
titration. Zytomed Systems offers 6 ml and 7 ml ready-to-use antibodies.
MAX-Line antibodies: These high-volume ready-to-use antibodies offer cost-effective solutions for
laboratories with manual as well as automated systems that have high throughput. They are available
in a 16 ml sizes.
Concentrated antibodies: To ensure highest flexibility in your immunohistochemistry protocol
Zytomed Systems offers 1 ml, 0.5 ml and 0.1 ml concentrated antibodies.
For a broad range of antibodies we offer protocol information for use on automated systems.
These protocols were provided by customers and have already been verified in the day-to-day routine
of an IHC laboratory. You can download a sheet with protocol recommendations from our homepage
or ask your local dealer for more information.
ACTH
Clone: SPM501
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU F, P Concentrate 1:400 1 ml 501-16454
Pretreat.: Citrate
Status: RUO
Actin alpha (Skeletal Muscle)
Clone: 5C5.F8.C7
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 0.1 ml 501-16650
P Concentrate 1:50
Pretreat.: Citrate 1 ml 501-16654
Status: RUO
Actin alpha (Smooth Muscle)
Clone: 1A4
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, MS, RT, CH 6 ml MSG030
P Ready-to-use -
Pretreat.: - 16 ml BMS001
Status: CE/IVD
0.5 ml MSK030-05
P, IF Concentrate 1:100
1 ml MSK030
ADH-5 Cocktail
Please refer to Cytokeratin 5 & 14.
10 www.zytomed-systems.comAFP (Alpha-Fetoprotein)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P, WB Concentrate 1:200 1 ml 501-2954
Pretreat.: -
Antibodies
Status: RUO
AFP (Alpha-Fetoprotein)
Clone: SP154
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, BV, DG, PG P Ready-to-use - 7 ml 501-4541
Pretreat.: Citrate 0.1 ml 501-4540
Status: RUO
P, WB Concentrate 1:100 0.5 ml 501-4542
1 ml 501-4544
Akt1, phosphorylated Ser473
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 501-13450
F, P Concentrate 1:25
Pretreat.: Citrate 1 ml 501-13454
Status: RUO
ALK/p80 (Anaplastic Lymphoma Kinase)
Clone: 5A4
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU P Concentrate 1:100 - 1:200 0.5 ml MSK096-05
Pretreat.: Citrate
Status: CE/IVD
Alpha-1-Antichymotrypsin
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P, WB Concentrate 1:100 1 ml 501-3454
Pretreat.: -
Status: RUO
Alpha-Fetoprotein
Please refer to AFP.
AMACR
Please refer to P504S.
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 11Amyloid Beta (A4)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Ready-to-use - 7 ml 501-3531
Pretreat.: - 0.1 ml 501-3530
Antibodies
Status: RUO
F, P, WB, IP Concentrate 1:100 0,5 ml 501-3532
1 ml 501-3534
Amyloid Beta Precursor Protein (APP)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT F, P, WB Concentrate 1:100 1 ml 501-2654
Pretreat.: Citrate
Status: RUO
Anaplastic Lymphoma Kinase
Please refer to ALK.
Androgen Receptor
Clone: SP107
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Ready-to-use - 7 ml 501-4071
Pretreat.: Citrate 0.1 ml 501-4070
Status: RUO
P, WB Concentrate 1:400 0.5 ml 501-4072
1 ml 501-4074
Annexin I (ANXA1)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.5 ml 501-14032
P Concentrate 1:25
Pretreat.: Citrate 1 ml 501-14034
Status: RUO
Apo-1 (Fas)
Please refer to CD95.
APP
Please refer to Amyloid Beta Precursor Protein.
12 www.zytomed-systems.comArginase-1
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 501-19280
Pretreat.: Citrate P, WB Concentrate 1:100 0.5 ml 501-19282
Antibodies
Status: RUO
1 ml 501-19284
Arginase-1
Clone: SP156
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 501-4560
Pretreat.: EDTA P Concentrate 1:100 0.5 ml 501-4562
Status: RUO
1 ml 501-4564
ATRX
Clone: 60.1
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU P, EL, WB Concentrate 1:200 50 µg 101-0630
Pretreat.: Citrate
Status: RUO
B-cells
Please refer to CD19, CD20, CD23, CD45RA, CD74, CD79a, pan B Cocktail, PAX.
Bax
Clone: SP47
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 502-3470
Pretreat.: Citrate P Concentrate 1:50 0.5 ml 502-3472
Status: RUO
1 ml 502-3474
BCL1
Please refer to Cyclin D1.
BCL2
Clone: E17
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 6 ml RBG016
Ready-to-use -
Pretreat.: Citrate 16 ml BRB055
Status: CE/IVD F, P
0.5 ml RBK016-05
Concentrate 1:25 - 1:100
1 ml RBK016
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 13BCL6
Clone: SP155
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 502-4550
Pretreat.: Citrate P, FL Concentrate 1:100 0.5 ml 502-4552
Antibodies
Status: RUO
1 ml 502-4554
Beta Catenin
Please refer to Catenin (beta).
BOB-1
Clone: SP92
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 502-3920
Pretreat.: Citrate P, WB Concentrate 1:100 0.5 ml 502-3922
Status: RUO
1 ml 502-3924
BRST-2
Please refer to GCDFP-15.
C3d (Complement factor)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG034
F, P
Pretreat.: Citrate Concentrate 1:100-1:500 0.5 ml RBK034-05
Status: CE/IVD
C4d (Complement factor)
Clone: A24-T
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG061
P
Pretreat.: Citrate Concentrate 1:100 - 1:200 0.5 ml RBK061-05
Status: CE/IVD
c-erbB1
Please refer to EGFr.
c-erbB2
Please refer to HER2.
c-erbB3
Please refer to HER3.
14 www.zytomed-systems.comCA 9 (Carbonic Anhydrase 9)
Clone: SP106
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.5 ml 503-4062
P, WB Concentrate 1:100
Pretreat.: Citrate 1 ml 503-4064
Antibodies
Status: RUO
CA 15-3 Antigen
Please refer to MUC1.
CA 19-9 Antigen (Colon)
Clone: 121SLE
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG094
P
Pretreat.: Citrate Concentrate 1:25 - 1:50 0.5 ml MSK094-05
Status: CE/IVD
CA 125
Clone: Ov185:1
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU P Ready-to-use - 6 ml MSG110
Pretreat.: Citrate
Status: RUO
Cadherin
Please refer to E-Cadherin, N-Cadherin und Ksp-Cadherin.
Cadherin 17
Clone: 1H3
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG105
P
Pretreat.: EDTA Concentrate 1:100 - 1:200 0.5 ml MSK105-05
Status: CE/IVD
Cadherin 17
Clone: SP183
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-4830
Pretreat.: EDTA P Concentrate 1:100 0.5 ml 503-4832
Status: RUO
1 ml 503-4834
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 15Cadherin (Pan)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:100 1 ml 503-2364
Pretreat.: Citrate
Antibodies
Status: RUO
Calcitonin
Clone: SP17
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT, DG, 0.5 ml RBK038-05
F, P Concentrate 1:100
PG, HS, SH 1 ml RBK038
Pretreat.: Citrate
Status: RUO
Caldesmon
Clone: E-89
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG040
F, P
Pretreat.: Citrate Concentrate 1:25 - 1:100 0.5 ml RBK040-05
Status: CE/IVD
CALLA
Please refer to CD10.
Calpain
Clone: SP81
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Concentrate 1:100 1 ml 503-3814
Pretreat.: Citrate
Status: RUO
Calpastatin
Clone: SP82
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Concentrate 1:100 1 ml 503-3824
Pretreat.: Citrate
Status: RUO
Calponin-1
Clone: EP789Y
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG041
F, P
Pretreat.: Citrate Concentrate 1:50 - 1:200 0.5 ml RBK041-05
Status: CE/IVD
16 www.zytomed-systems.comCalretinin
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS 6 ml RBG003
Ready-to-use -
Pretreat.: Citrate 16 ml BRB022
Antibodies
Status: CE/IVD P
0.5 ml RBK003-05
Concentrate 1:100 - 1:200
1 ml RBK003
Carbonic Anhydrase IX (CA IX)
Please refer to CA 9.
Carcinoembryonic Antigen
Please refer to CEA.
Caspase-3, cleaved (CPP32)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT P Concentrate 1:50 - 1:200 0.5 ml RBK009-05
Pretreat.: Citrate
Status: RUO
Catenin (beta)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Ready-to-use - 7 ml 503-2261
Pretreat.: Citrate 0.1 ml 503-2260
Status: RUO
P, WB Concentrate 1:250 0.5 ml 503-2262
1 ml 503-2264
Catenin delta
Please refer to p120.
Cathepsin D
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:50 1 ml 503-2824
Pretreat.: Citrate
Status: RUO
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 17CD1a
Clone: EP3622
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG045
F, P
Pretreat.: Citrate or EDTA Concentrate 1:25 - 1:100 0.5 ml RBK045-05
Antibodies
Status: CE/IVD
CD3
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 6 ml RBG015
Ready-to-use -
Pretreat.: Citrate 16 ml BRB063
Status: CE/IVD F, P
0.5 ml RBK015-05
Concentrate 1:200 - 1:400
1 ml RBK015
CD3
Clone: SP7
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS 6 ml RBG024
F, P Ready-to-use -
Pretreat.: Citrate 16 ml BRB041*
Status: RUO, *CE/IVD
0.5 ml RBK024-05
F, P, WB Concentrate 1:150 - 1:200
1 ml RBK024
CD4
Clone: SP35
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Ready-to-use - 16 ml BRB042
Pretreat.: Citrate
Status: CE/IVD
CD4
Clone: SP35
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:50 1 ml 503-3354
Pretreat.: Citrate or EDTA
Status: RUO
CD5
Clone: SP19
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:50 - 1:100 0.5 ml RBK023-05
Pretreat.: Citrate
Status: RUO
18 www.zytomed-systems.comCD5
Clone: 4C7
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG120
F, P
Pretreat.: Citrate Concentrate 1:100 0.5 ml MSK120-05
Antibodies
Status: CE/IVD
CD7
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-18930
Pretreat.: Citrate P Concentrate 1:200 0.5 ml 503-18932
Status: RUO
1 ml 503-18934
CD8
Clone: SP16
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Ready-to-use - 16 ml BRB036
Pretreat.: Citrate
Status: CE/IVD
CD8
Clone: C8/144B
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG011
Pretreat.: EDTA F, P 0.5 ml MSK011-05
Status: CE/IVD Concentrate 1:100
1 ml MSK011
CD10 (CALLA)
Clone: 56C6
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, RT 6 ml MSG070
Ready-to-use -
Pretreat.: Citrate 16 ml BMS043
Status: CE/IVD F, P
0.5 ml MSK070-05
Concentrate 1:25 - 1:50
1 ml MSK070
CD10 (CALLA)
Clone: SP67
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-3670
Pretreat.: EDTA P, WB Concentrate 1:100 0.5 ml 503-3672
Status: RUO
1 ml 503-3674
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 19CD11c
Clone: 5D11
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG093
P
Pretreat.: Citrate or EDTA Concentrate 1:50 - 1:100 0.5 ml MSK093-05
Antibodies
Status: CE/IVD
CD13
Clone: SP182
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-4820
Pretreat.: EDTA P, FL Concentrate 1:100 0.5 ml 503-4822
Status: RUO
1 ml 503-4824
CD14
Clone: EPR3653
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:50 - 1:200 0.5 ml RBK033-05
Pretreat.: Citrate
Status: CE/IVD
CD15
Clone: MMA + BY87
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG108
Ready-to-use -
Pretreat.: Citrate P 16 ml BMS066*
Status: CE/IVD, *RUO
Concentrate 1:50 - 1:100 0.5 ml MSK108-05
CD16a
Clone: SP189
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Ready-to-use - 7 ml 506-4891
Pretreat.: EDTA 0.1 ml 506-4890
Status: RUO
P, WB Concentrate 1:100 0.5 ml 506-4892
1 ml 506-4894
CD19
Clone: LE-CD19
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU P Concentrate 1:100 - 1:200 0.5 ml MSK043-05
Pretreat.: Citrate
Status: RUO
20 www.zytomed-systems.comCD20
Clone: L26
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG008
Ready-to-use -
Pretreat.: optional: Citrate 16 ml BMS003
Antibodies
Status: CE/IVD F, P
0.5 ml MSK008-05
Concentrate 1:100 - 1:200
1 ml MSK008
CD20
Clone: SP32
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.5 ml RBK030-05
P Concentrate 1:100
Pretreat.: - 1 ml RBK030
Status: RUO
CD21
Clone: EP3093
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG036
F, P
Pretreat.: Citrate Concentrate 1:50 - 1:200 0.5 ml RBK036-05
Status: CE/IVD
CD22
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-19020
Pretreat.: Citrate P Concentrate 1:200 0.5 ml 503-19022
Status: RUO
1 ml 503-19024
CD23
Clone: SP163
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.5 ml 503-4632
P, WB Concentrate 1:50
Pretreat.: Citrate 1 ml 503-4634
Status: RUO
CD25
Clone: SP176
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT 0.1 ml 503-4760
Pretreat.: EDTA P, WB Concentrate 1:200 0.5 ml 503-4762
Status: RUO
1 ml 503-4764
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 21CD30 (Ki-1)
Clone: Ber-H2
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG061
Pretreat.: Citrate F, P 0.5 ml MSK061-05
Antibodies
Status: CE/IVD Concentrate 1:40 - 1:80
1 ml MSK061
CD31 (PECAM-1)
Clone: JC70
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG091
Ready-to-use -
Pretreat.: Citrate 16 ml BMS044*
Status: RUO, *CE/IVD F, P
0.5 ml MSK091-05
Concentrate 1:50 - 1:200
1 ml MSK091
CD31 (PECAM-1)
Clone: SP38
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, PG Ready-to-use - 7 ml 503-3381
P
Pretreat.: Citrate Concentrate 1:50 1 ml 503-3384
Status: RUO
CD34
Clone: QBEnd/10
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 16 ml BMS045*
Pretreat.: optional: Citrate F, P 0.5 ml MSK122-05
Status: RUO, *CE/IVD 1:50 - 1:200 1:50 - 1:200
1 ml MSK122
CD38
Clone: SP149
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Ready-to-use - 7 ml 503-4491
Pretreat.: Citrate 0.1 ml 503-4490
Status: RUO
P, FL Concentrate 1:100 0.5 ml 503-4492
1 ml 503-4494
CD42b
Clone: SP202
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 7 ml 503-5021
Pretreat.: EDTA 0.1 ml 503-5020
Status: RUO P
Concentrate 1:100 0.5 ml 503-5022
1 ml 503-5024
22 www.zytomed-systems.comCD42b
Clone: SP219
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-5190
Pretreat.: Citrat P, FL Concentrate 1:100 0.5 ml 503-5192
Antibodies
Status: RUO
1 ml 503-5194
CD43
Clone: DF-T1
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, RT 0.5 ml MSK065-05
F, P Concentrate 1:50 - 1:100
Pretreat.: Citrate (optional) 1 ml MSK065
Status: RUO
CD45 (LCA)
Clone: PD7/26+2B11
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG054
Ready-to-use -
Pretreat.: Citrate 16 ml BMS046
Status: CE/IVD F, P
0.5 ml MSK054-05
Concentrate 1:50 - 1:100
1 ml MSK054
CD56
Clone: RCD56
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT 6 ml RBG050
P Ready-to-use -
Pretreat.: EDTA 16 ml BRB039
Status: CE/IVD
0.5 ml RBK050-05
P, WB Concentrate 1:100 - 1:500
1 ml RBK050
CD61
Clone: 2f2
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG086
Pretreat.: EDTA F, P 0.5 ml MSK086-05
Status: CE/IVD Concentrate 1:25 - 1:100
1 ml MSK086
CD63
Clone: SPM524
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU F, P Concentrate 1:200 1 ml 503-17514
Pretreat.: Citrate
Status: RUO
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 23CD66
Please refer to CEA.
CD68
Antibodies
Clone: KP1
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG055
Pretreat.: Citrate F, P 0.5 ml MSK055-05
Status: CE/IVD Concentrate 1:50 - 1:100
1 ml MSK055
CD79a
Clone: JCB117
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG036
Ready-to-use -
Pretreat.: Citrate 16 ml BMS005
Status: CE/IVD F, P
0.5 ml MSK036-05
Concentrate 1:50 - 1:100
1 ml MSK036
CD79a
Clone: SP18
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 6 ml RBG029
Pretreat.: Citrate F, P 0.5 ml RBK029-05
Status: RUO Concentrate 1:100 - 1:200
1 ml RBK029
CD79b
Clone: SP240
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-5400
Pretreat.: Citrate P, WB Concentrate 1:100 0.5 ml 503-5402
Status: RUO
1 ml 503-5404
CD95 (Fas, Apo-1)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:60 1 ml 503-2504
Pretreat.: Citrate
Status: RUO
24 www.zytomed-systems.comCD95L (Fas Ligand)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT F, P, WB Concentrate 1:100 1 ml 506-2714
Pretreat.: Citrate
Antibodies
Status: RUO
CD99
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-3390
Pretreat.: Citrate F, P Concentrate 1:200 0.5 ml 503-3392
Status: RUO
1 ml 503-3394
CD105 (Endoglin, TGF-beta1/3-Receptor)
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:50 1 ml 503-4234
Pretreat.: Citrate
Status: RUO
CD117/c-kit
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 7 ml 503-1441
Pretreat.: Citrate 0.1 ml 503-1440
Status: RUO F, P
Concentrate 1:100 0.5 ml 503-1442
1 ml 503-1444
CD138 (Syndecan-1)
Clone: B-A38
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, PG Ready-to-use - 6 ml MSG063
Pretreat.: Citrate F, P 0.5 ml MSK063-05
Status: CE/IVD Concentrate 1:200
1 ml MSK063
CD140a
Please refer to PDGFr-alpha.
CD140b
Please refer to PDGFr-beta.
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 25CD163
Clone: SP96
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Concentrate 1:100 1 ml 503-3964
Pretreat.: EDTA
Antibodies
Status: RUO
CD169
Clone: SP213
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 519-5130
Pretreat.: Citrate P Concentrate 1:100 0.5 ml 519-5132
Status: RUO
1 ml 519-5134
CD178
Please refer to CD95L.
CD207
Please refer to Langerin.
CD227
Please refer to MUC1 und EMA.
CD246
Please refer to ALK.
CD274
Please refer to PD-L1.
CD278
Clone: SP98
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS 0.1 ml 509-3980
Pretreat.: EDTA P Concentrate 1:100 0.5 ml 509-3982
Status: RUO
1 ml 509-3984
CD279
Please refer to PD1.
CD308
Please refer to VEGFr-1 (Flt-1).
26 www.zytomed-systems.comCD309
Please refer to VEGFr-2 (Flk-1).
CD310
Antibodies
Please refer to VEGFr-3 (Flt-4).
CD324
Please refer to E-Cadherin.
CD326
Please refer to Epithelial Specific Antigen.
CD331 - CD333
Please refer to FGFR1 bis FGFR3.
CD380
Please refer to HER2.
CDH17
Please refer to Cadherin 17.
Cdk4 (Cyclin dependent Kinase)
Clone: DCS-31.2
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, MS, RT F, P, WB, Concentrate 1:100 - 1:250 100 µg 603-1840
Pretreat.: Citrate
Status: RUO
CDw325
Please refer to N-Cadherin.
CDX-2
Clone: EPR2764Y
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 6 ml RBG019
Ready-to-use -
Pretreat.: Citrate 16 ml BRB028
Status: CE/IVD F, P
0.5 ml RBK019-05
Concentrate 1:50 - 1:100
1 ml RBK019
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 27CEA
Clone: Col-1
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG022
Ready-to-use -
Pretreat.: - 16 ml BMS029
Antibodies
Status: CE/IVD F, P
0.5 ml MSK022-05
Concentrate 1:100 - 1:200
1 ml MSK022
Chromogranin A
Clone: LK2H10
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, PG 6 ml MSG062
Ready-to-use -
Pretreat.: - 16 ml BMS018
Status: CE/IVD F, P
0.5 ml MSK062-05
Concentrate 1:200 - 1:400
1 ml MSK062
cKit
Please refer to CD117.
Claudin 1
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT Ready-to-use - 7 ml 503-3411
F, P
Pretreat.: Citrate Concentrate 1:200 1 ml 503-3414
Status: RUO
Claudin 4
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS 0.1 ml 503-3980
Pretreat.: Citrate P Concentrate 1:200 0.5 ml 503-3982
Status: RUO
1 ml 503-3984
Claudin 7
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT F, P Concentrate 1:200 1 ml 503-10594
Pretreat.: Citrate
Status: RUO
CMV
Please refer to Cytomegalovirus.
28 www.zytomed-systems.comConnexin 43
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT F, P, WB, IP Concentrate 1:50 1 ml 503-2744
Pretreat.: Citrate
Antibodies
Status: RUO
COX-1
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU F, P Concentrate 1:100 1 ml 503-14314
Pretreat.: Citrate
Status: RUO
COX-2
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT F, P Ready-to-use - 7 ml 503-3031
Pretreat.: Citrate F, P, WB, IP Concentrate 1:100 1 ml 503-3034
Status: RUO
CTLA4
Clone: UMAB249
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG116
P
Pretreat.: Citrate Concentrate 1:100 0.5 ml MSK116-05
Status: CE/IVD
CUL-1, Cullin 1
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-3790
P Concentrate 1:50
Pretreat.: Citrate 0.5 ml 503-3792
Status: RUO
Cyclin D1
Clone: SP4
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU, MS, RT F, P Concentrate 1:50 - 1:100 0.5 ml RBK025-05
Pretreat.: Citrate or EDTA
Status: RUO
Cyclin D3
Clone: SP207
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-5070
Pretreat.: - P, WB Concentrate 1:100 0.5 ml 503-5072
Status: RUO
1 ml 503-5074
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 29Cyclin Dependent Kinase
Please refer to Cdk.
Cyclooxygenase
Antibodies
Please refer to COX-1 und COX-2.
Cytokeratin 5 & 6
Clone: D5/16B4
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG034
Ready-to-use -
Pretreat.: Citrate 16 ml BMS017
Status: CE/IVD F, P
0.5 ml MSK034-05
Concentrate 1:50 - 1:100
1 ml MSK034
Cytokeratin 5 & 14
Clone: XM26+LL002
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG106
Ready-to-use -
Pretreat.: Citrate 16 ml BMS023
Status: CE/IVD F, P
0.5 ml MSK106-05
Concentrated 1:50 - 1:100
1 ml MSK106
Cytokeratin 6
Clone: SP87
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU 0.1 ml 503-3870
Pretreat.: Citrate P, WB Concentrate 1:200 0.5 ml 503-3872
Status: RUO
1 ml 503-3874
Cytokeratin 7
Clone: OV-TL 12/30
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG032
Ready-to-use -
Pretreat.: Citrate or 16 ml BMS030
Fast Enzyme F, P
0.5 ml MSK032-05
Status: CE/IVD Concentrate 1:100 - 1:200
1 ml MSK032
30 www.zytomed-systems.comCytokeratin 8
Clone: SP102
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 7 ml 503-4021
Pretreat.: Citrate 0.1 ml 503-4020
Antibodies
Status: RUO P
Concentrate 1:100 0.5 ml 503-4022
1 ml 503-4024
Cytokeratin 8 & 18
Clone: IVT2000
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG035
Pretreat.: Citrate or P 0.5 ml MSK035-05
Fast Enzyme Concentrate 1:100 - 1:200
1 ml MSK035
Status: RUO
Cytokeratin 10
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Concentrate 1:100 0.1 ml 503-18980
Pretreat.: EDTA
Status: RUO
Cytokeratin 14
Clone: SP53
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P Concentrate 1:100 1 ml 503-3534
Pretreat.: Citrate
Status: RUO
Cytokeratin 17
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU P, WB Concentrate 1:200 1 ml 503-18924
Pretreat.: EDTA
Status: RUO
Cytokeratin 18
Clone: DC-10
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG016
Pretreat.: Citrate or F, P 0.5 ml MSK016-05
Fast Enzyme Concentrate 1:100 - 1:200
1 ml MSK016
Status: RUO
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 31Cytokeratin 19
Clone: A53-B/A2.26
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml MSG017
Pretreat.: Citrate F, P 0.5 ml MSK017-05
Antibodies
Status: CE/IVD Concentrate 1:200 - 1:300
1 ml MSK017
Cytokeratin 20
Clone: Ks20.8
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU 6 ml MSG119
Ready-to-use -
Pretreat.: proteolytic 16 ml BMS037
Status: CE/IVD P
0.5 ml MSK119-05
Concentrate 1:25 - 1:50
1 ml MSK119
Cytokeratin Broad Spectrum
Clone: AE1+AE3
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, MS, RT, DG 6 ml MSG019
Ready-to-use -
Pretreat.: Citrate or 16 ml BMS006
Fast Enzyme F, P
0.5 ml MSK019-05
Status: CE/IVD Concentrate 1:100 - 1:200
1 ml MSK019
Cytokeratin (HMW)
Clone: 34betaE12
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, RB, DG 6 ml MSG027
Ready-to-use -
Pretreat.: Citrate, Pepsin 16 ml BMS015
or Fast Enzyme F, P
0.5 ml MSK027-05
Status: CE/IVD Concentrate 1:25 - 1:50
1 ml MSK027
Cytokeratin (OSCAR)
Clone: OSCAR
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU Ready-to-use - 6 ml Z-465-26-Y
F, P
Pretreat.: Citrate Concentrate 1:40 1 ml Z-465-01-Y
Status: RUO
32 www.zytomed-systems.comCytokeratin Pan
Clone: KL1
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, RT, MS, RB, 6 ml MSG113
Ready-to-use -
FE, DG, ZF 16 ml BMS056
Antibodies
Pretreat.: Citrate P
0.5 ml MSK113-05
Status: CE/IVD Concentrate 1:100
1 ml MSK113
Cytokeratin Pan Plus (AE1 & AE3 & 5D3)
Clone: AE1+AE3+5D3
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, MS, RT 6 ml MSG098
Ready-to-use -
Pretreat.: Citrate, EDTA P 16 ml BMS057
or proteolytic
Concentrate 1:50 - 1:100 0.5 ml MSK098-05
Status: CE/IVD
Cytomegalovirus (CMV)
Clone: DDG9+CCH2
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: CMV Ready-to-use - 6 ml MSG121
P
Pretreat.: Citrate Concentrate 1:10 - 1:25 0.5 ml MSK121-05
Status: RUO
D2-40 (Lymphatic Endothelium Marker)
Please refer to Podoplanin.
Desmin
Clone: D33
Method Format Dilution Amount Cat. No.
Host: Mouse
Reactivity: HU, MS, RT 6 ml MSG053
Ready-to-use -
Pretreat.: Citrate 16 ml BMS007
Status: CE/IVD F, P
0.5 ml MSK053-05
Concentrate 1:25 - 1:50
1 ml MSK053
DOG1
Clone: polyclonal
Method Format Dilution Amount Cat. No.
Host: Rabbit
Reactivity: HU Ready-to-use - 7 ml 516-16711
F, P
Pretreat.: Citrate Concentrate 1:100 1 ml 516-16714
Status: RUO
Reactivity: BV = Cow; CH = Chicken; DG = Dog; FE = Cat; FG = Frog, GT = Goat; GP = Guinea pig; HM = Hamster; HS = Horse; HU = Human; MO = Monkey; MS = Mouse; PG = Pig; RB = Rabbit; RT = Rat; SH = Sheep; XE = Xenopus; ZF = Zebra fish a. o. = and others
Method: EL = ELISA; F = frozen sections IHC; FL = Flow Cytometry; IF = Immunofluorescense; IP = Immunoprecipitation; P = paraffin section IHC; WB = Western Blot
Status: CE/IVD = for in vitro diagnostic use; RUO = Research use only 33You can also read
